Original manuscript published in Science Advances

SARS-CoV-2 antibody magnitude and detectability are driven by disease severity, timing, and assay

Our epidemiologists working in close partnership with our clinical and laboratory scientists measured antibodies on 128 LIINC participants over the first 6 months in the study. They used 14 different types of antibody tests – some of which are widely available in doctor’s offices and hospitals and others which are research-only – and found that […]

Original manuscript published in the Journal of NeuroVirology

Persistent COVID-19-associated neurocognitive symptoms in non-hospitalized patients

Our neurology collaborators analyzed data from the first 100 volunteers in LIINC to identify people with persistent neurological complaints. They performed an in-depth evaluation of two people reporting “brain fog” issues using neurocognitive testing. These findings led to the implementation of the Coronavirus Neurocognitive Study (CNS) which is now seeing LIINC volunteers to try to […]